- Home
- INTZ vs BRNS Comparison
INTZ vs BRNS Comparison
Compare INTZ & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTZ | BRNS |
|---|---|---|
| Founded | 1983 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 24.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INTZ | BRNS |
|---|---|---|
| Price | $0.66 | $0.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.75 | $4.00 |
| AVG Volume (30 Days) | ★ 210.5K | 34.5K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,015,000.00 | N/A |
| Revenue This Year | $25.34 | N/A |
| Revenue Next Year | $14.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.56 | N/A |
| 52 Week Low | $0.66 | $0.51 |
| 52 Week High | $2.27 | $1.83 |
Technical Indicators
Market Signals| Indicator | INTZ | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 42.55 |
| Support Level | $0.70 | $0.55 |
| Resistance Level | $0.88 | $0.75 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 12.67 | 19.78 |
Price Performance
Historical ComparisonAbout INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.